647 results on '"Sukasem, Chonlaphat"'
Search Results
2. Novel genetic variants of HLA gene associated with Thai Behcet’s disease (BD) patients using next generation sequencing technology
3. Pharmacogenomics of Preeclampsia therapies: Current evidence and future challenges for clinical implementation
4. An increase in urinary primaquine and a reduction in urinary primaquine-5,6-orthoquinone in the Thai population with CYP2D6 reduced enzyme function
5. IFN-γ ELISpot-enabled machine learning for culprit drug identification in nonimmediate drug hypersensitivity
6. A precision medicine approach to personalized prescribing using genetic and nongenetic factors for clinical decision-making
7. A comprehensive Thai pharmacogenomics database (TPGxD‐1): Phenotype prediction and variants identification in 942 whole‐genome sequencing data
8. Risperidone plasma concentrations are associated with hyperprolactinemia in autism spectrum disorder children: The impact of CYP2D6 polymorphisms
9. Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population
10. Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus
11. Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implications
12. HLA Class-II‒Restricted CD8+ T Cells Contribute to the Promiscuous Immune Response in Dapsone-Hypersensitive Patients
13. The Diversity of CYP2C19 Polymorphisms in the Thai Population: Implications for Precision Medicine.
14. Molecular identification of HLA‐B75 serotype markers by qPCR: A more inclusive pharmacogenetic approach before carbamazepine prescription.
15. SJS/TEN 2019: From science to translation
16. Development and validation of a liquid chromatography-tandem mass spectrometry method for determination of ibuprofen in human plasma
17. CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients
18. Pharmacogenomics of Preeclampsia therapies: Current evidence and future challenges for clinical implementation
19. Reliability and validity of the Thai Drug Hypersensitivity Quality of Life Questionnaire : a multi-center study
20. Southeast Asian Pharmacogenomics Research Network (SEAPharm) : Current Status and Perspectives
21. Allele frequencies of single nucleotide polymorphisms of clinically important drug-metabolizing enzymes CYP2C9, CYP2C19, and CYP3A4 in a Thai population
22. Relationship between CYP2D6 genotype, activity score and phenotype in a pediatric Thai population treated with risperidone
23. Pharmacogenomics: A New Approach for Preventing Severe Cutaneous Adverse Drug Reactions
24. Clinical Pharmacogenomics and Personalized Medicine: New Strategies to Maximize Drug Efficacy and Avoid Adverse Drug Reaction
25. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs
26. The association of CYP2C19LoF alleles with adverse clinical outcomes in stroke patients taking clopidogrel: An updated meta‐analysis.
27. Pharmacogenomics of chloroquine and hydroxychloroquine: current evidence and future implications
28. Cost-effectiveness analysis of HLA-B*13:01 screening for the prevention of co-trimoxazole-induced severe cutaneous adverse reactions among HIV-infected patients in Thailand
29. Updates in SJS/TEN: collaboration, innovation, and community
30. Novel Genetic Variants of HLA Gene Associated with Thai Behcet’s Disease (BD) Patients Using Next Generation Sequencing Technology
31. Genotypic and phenotypic characteristics of co-trimoxazole-induced cutaneous adverse reactions
32. A LC/MS/MS method for determination of tenofovir in human plasma and its application to toxicity monitoring
33. Determination of plasma Levetiracetam level by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS) and its application in pharmacokinetics studies in neonates
34. SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation
35. Risk factors for sulfamethoxazole/trimethoprim‐induced severe cutaneous adverse reactions.
36. UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder
37. Clinical pharmacogenomics implementation in Thailand: a dream come true
38. Association between Q192R PON1 genetic polymorphism and major adverse cardiovascular events in patients treated with clopidogrel: an updated meta-analysis
39. Development and validation of a reliable method for thiopurine methyltransferase (TPMT) enzyme activity in human whole blood by LC–MS/MS: An application for phenotypic and genotypic correlations
40. Impact of risperidone on leptin and insulin in children and adolescents with autistic spectrum disorders
41. Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy
42. Characterization of Drug-Specific CD4+ T-Cells Reveals Possible Roles of HLA Class II in the Pathogenesis of Carbamazepine Hypersensitivity Reactions
43. Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
44. Azole antifungals and inter-individual differences in drug metabolism: the role of pharmacogenomics and precision medicine
45. Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022
46. Pharmacogenomics in Asians: Differences and similarities with other human populations
47. Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels
48. A prospective observational study of CYP2C19 polymorphisms and voriconazole plasma level in adult Thai patients with invasive aspergillosis
49. Correlation of UGT1A1*28 and *6 polymorphisms with irinotecan-induced neutropenia in Thai colorectal cancer patients
50. Determination of irinotecan, SN‐38 and SN‐38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.